Trial site
Anhui Province cancer hospital
Hefei, Anhui 230031, ChinaNot linked to an institution yet
- 3running trials
- 7closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Phase
- Phase 37 trials
- Phase 22 trials
- Status
- Completed6 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche7 trials
- Allist Pharmaceuticals, Inc.1 trial
- Antengene Corporation1 trial
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer
NCT05945927· Hoffmann-La Roche· Source
Completed
A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma
NCT05051891· Phase 3· Beijing InnoCare Pharma Tech Co., Ltd.· Source
Terminated
A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)
NCT04933227· Phase 2· Hoffmann-La Roche· Source
Completed
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma
NCT04540211· Phase 3· Hoffmann-La Roche· Source
Completed
A Study of Evaluating the Safety and Efficacy of ATG-010 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT03992339· Phase 2· Antengene Corporation· Source
Completed
A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation
NCT04102098· Phase 3· Hoffmann-La Roche· Source
Completed
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
NCT02486718· Phase 3· Hoffmann-La Roche· Source
Report an error